MSD Korea launches V65 campaign for Vioxx in Korea

MSD Korea said it has initiated a V65 campaign towards local doctors and patients from last September as part of its efforts to promote is lead product Vioxx for the treatment of arthritis, adding that its earlier "Vonmax Club" campaign, which has launched last May, is gaining good reputation from doctors and patients.

"The V65 campaign is intended for better management of practitioners in t...